Related Experiment Video

Updated: Apr 6, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.2K

Down-regulation of Sphk2 suppresses bladder cancer progression

Erlin Sun1, Wenbo Zhang2, Lining Wang3

  • 1Department of Urology, Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, No. 23, Pingjiang Road, Hexi District, Tianjin, People's Republic of China. irene_sunsun@yahoo.com.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|July 31, 2015
PubMed

Insights

Sphingosine kinase 2 (SphK2) is overexpressed in bladder cancer. Inhibiting SphK2 reduces cancer cell proliferation and migration while increasing apoptosis, suggesting it as a potential therapeutic target.

Area of Science:

  • Uro-oncology
  • Molecular biology
  • Cancer research

Background:

  • Bladder cancer is a prevalent malignancy globally and in China.
  • Abnormal sphingosine kinase 2 (SphK2) expression correlates with tumor progression and poor survival.
  • The specific role of SphK2 in bladder cancer cells requires elucidation.

Purpose of the Study:

  • To investigate SphK2 expression in bladder cancer tissues and cell lines.
  • To determine the impact of SphK2 on bladder cancer cell proliferation, metastasis, and apoptosis in vitro.

Main Methods:

  • Quantitative analysis of SphK2 expression in tumor vs. adjacent non-neoplastic tissues.
  • SphK2 gene silencing using siRNA in T24 bladder cancer cells.
  • In vitro assays for cell proliferation, apoptosis, and cell migration (Transwell assay).

Main Results:

  • SphK2 is significantly upregulated in bladder cancer tissues and cell lines compared to normal counterparts.
  • SphK2 silencing inhibited T24 cell proliferation in vitro.
  • SphK2 knockdown led to a significant increase in apoptotic bladder cancer cells.
  • Transwell assays demonstrated substantial inhibition of cell migration upon SphK2 knockdown.

Conclusions:

  • SphK2 is overexpressed in bladder cancer.
  • SphK2 plays a crucial role in promoting bladder cancer cell proliferation and metastasis.
  • Targeting SphK2 through inhibition may represent a promising therapeutic strategy for bladder cancer.
Keywords:
ApoptosisBladder cancerMigrationProliferationSphK2

More Related Videos

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

9.6K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K